La Nueva Eugenesia
By Jesse Reynolds,
Z Magazine
| 11. 01. 2002
Mientras escribo este artículo, delegados de todo el
mundo se reúnen en la sede de Naciones Unidas para tomar
medidas conducentes a la creación de una convención
internacional que prohíba la clonación humana
reproductiva. La clonación es la tecnología de
manipulación genética y reproductiva de seres
humanos más reciente y llamativa, que ha despertado una
gran polémica y mantiene a la sociedad dividida. Además,
durante varios años, periódicos universitarios
han publicado casos de pagos de ingentes sumas a "donantes"
de óvulos con características concretas (véase
"Tecnologías de reproducción asistida"
en el número de julio/agosto de 2002 de Z Magazine).
Recientemente se ha hablado del diagnóstico genético
previo a la implantación, que consiste en el análisis
de los embriones para averiguar si poseen ciertas características
genéticas antes de implantarse mediante la técnica
de fecundación in vitro, con vistas a seleccionar el
sexo o descartar enfermedades hereditarias. La ingeniería
genética para rasgos hereditarios, la tecnología
susceptible de causar el mayor impacto social y biológico
hasta el momento, pronto suscitará un debate público.
La clonación humana con fines reproductivos ya no es
considerada...
Related Articles
What We Inherit by Sam Trejo and Daphne O. Martschenko; and Original Sin by Kathryn Paige Harden have a great deal in common, with substantial differences in style and emphasis. Both books attempt, in different ways, to show the reader just where current research into human genomics stands, where that might be going, and why the authors are interested. In short, the influence of genomic research on our societies is already large and seems likely to change them in ways...
By Dan Falk, Nautilus | 08.20.2026
The pseudoscience of eugenics, founded on the mistaken notion that nature envisions some “right” combination of genes, and that selective breeding can improve the human race, is making a comeback. While the heyday of eugenics was a century ago, the...
By Emily Packard Dawson and Lainie Friedman Ross, MedPage Today | 08.18.2026
Few things evoke a greater sense of desperation than a parent seeking an experimental treatment for their child. That desperation can make even extraordinary risks seem worth taking. This dynamic has come into stark relief after Mei, a 6-year-old girl...
By Ryan Cross, Endpoints News | 08.20.2026
China’s cheap, fast and quiet system for testing cutting-edge medicines is facing scrutiny after the deaths of three people in investigator-initiated trials.
The studies, also known as IITs, allow experimental cell and gene therapies to be tested without oversight from...
